SWK Holdings Corporation to Report Fourth Quarter and Full-Year 2022 Financial Results

Rhea-AI Summary

SWK Holdings Corporation (Nasdaq: SWKH), a specialty finance firm focused on life sciences, is set to host a conference call and live audio webcast on April 3, 2023, at 10:00 a.m. ET. The call will cover the corporate and financial results for the fourth quarter and full year of 2022. Interested investors can participate by calling (844) 378-6488 (U.S.) or (412) 317-1079 (International), or by accessing the webcast on the company's website. SWK specializes in non-dilutive financing for small- and mid-sized healthcare companies, providing flexible funding solutions ranging from $5.0 million to $25.0 million.

Positive

• SWK specializes in non-dilutive financing solutions for healthcare companies.
• The company's financing structures range from $5.0 million to $25.0 million, which can attract diverse clients.

Negative

• None.

Conference Call and Live Audio Webcast Scheduled for Monday, April 3, 2023, at 10:00 a.m. ET

DALLAS, March 31, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced today that the Company will host a conference call and live audio webcast on Monday, April 3, 2023, at 10:00 a.m. ET, to discuss its corporate and financial results for the fourth quarter and full year of 2022.

Interested participants and investors may access the conference call by dialing either:

• (844) 378-6488 (U.S.)
• (412) 317-1079 (International)

An audio webcast will be accessible via the Investors Events & Presentations section of the SWK Holdings' website: https://swkhold.investorroom.com/events. An archive of the webcast will remain available for 90 days beginning at approximately 11:30 a.m. ET, on April 3, 2023.

About SWK Holdings Corporation

SWK Holdings Corporation is a life science-focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. SWK's unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. SWK also owns Enteris BioPharma, whose Peptelligence® and ProPerma® drug delivery technologies create oral formulations of peptide-based and BCS class II, III, and IV small molecules. Additional information on the life science finance market is available on the Company's website at www.swkhold.com. 

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors which, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

View original content to download multimedia:https://www.prnewswire.com/news-releases/swk-holdings-corporation-to-report-fourth-quarter-and-full-year-2022-financial-results-301786624.html

SOURCE SWK Holdings Corporation

FAQ

When will SWK Holdings report its financial results?

SWK Holdings will report its financial results for the fourth quarter and full year of 2022 on April 3, 2023.

How can I join the SWK Holdings conference call?

You can join the SWK Holdings conference call by dialing (844) 378-6488 for U.S. participants or (412) 317-1079 for international participants.

What time is the SWK Holdings conference call scheduled?

The conference call is scheduled for 10:00 a.m. ET on April 3, 2023.

Where can I access the audio webcast for SWK Holdings?

The audio webcast can be accessed via the Investors Events & Presentations section on SWK Holdings' website.